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Kounissyndrome,alsonamedas“allergicanginasyndrome,”isadiagnosisinwhichexposuretoanallergencausesmostlycoronary
spasmandrarelyplaquerupture,resultinginischemicmyocardialevents.Myocardialbridgingisdeﬁnedasanintramuralsegment
of a coronary artery and its systolic compression by overlying ﬁbers. Myocardial bridging generally has a benign prognosis
and mostly aﬀects the mid portion of left anterior descending coronary artery. However, some cases with myocardial ischemia,
infarction,andsuddendeathhavealsobeenreported.A17-year-oldboypresentedtotheclinicwithacuteanterolateralmyocardial
infarction after having ﬁrst dose of clindamycin and diagnosed as Kounis syndrome. Further diagnostic workup of the patient
showed myocardial bridging at the mid left anterior descending artery. In this report, we present the combination of Kounis
syndrome and myocardial bridging leading to myocardial infarction at young age.
1.Introduction
Myocardial bridging (MB) is called when a segment of a
major coronary artery courses intramurally. The intramural
part is named as the “tunnelled segment,” and mostly the
mid portion of the left anterior descending coronary artery
(LAD) is aﬀected [1, 2]. There is a temporary systolic
narrowing of the coronary lumen, which sometimes causes
symptoms usually in middle-aged man, as typical or atypical
chest pain related or unrelated with excercise [3–5]. It is
usually a benign anatomical variation; however, in some
cases myocardial ischemia, infarction, arrhythmias, and
sudden cardiac death may also occur [6, 7].
Myocardial ischemia signs and symptoms accompanied
by allergic or hypersensitivity and anaphylactic or anaphy-
lactoid reactions are deﬁned as Kounis syndrome (KS) [8].
It is also referred as a new reason for coronary artery
spasm [9, 10]. There are very rare well-deﬁned Kounis cases
in the literature. Many drugs, environmental factors, and
conditions that can cause allergic reactions may also be
the causes for KS [9, 10]. So far two types of KS have
been deﬁned [10]. Type 1 is seen in patients who have
normal coronary arteries, without predisposing factors for
coronary artery disease. Mast cell activation and vasospasm
are the main causes, and this type represents manifestations
of endothelial dysfunction and microvascular angina. Type 2
variant is seen in patients who have dormant atheromatous
plaques. Mediators of acute allergic episode enhance plaque
erosion which may progress into myocardial infarction (MI)
[10, 11]. Prognosis of patients with Type 1 KS is better than
Type 2 cases. Prognosis depends on the magnitude of the
allergic reaction, patient’s sensitivity, comorbidities, allergen
concentration, and allergen’s portal of entrance to body [11].
The most frequent symptoms are retrosternal chest pain,
dyspnea, palpitation, weakness, nausea, urticaria, itchiness,
sweating, and hypotonia [11].
In this report, we have a case Type 1 KS together with
myocardial bridging at the mid portion of the LAD leading
to acute anterolateral myocardial infarction in a 17-year-old
male patient.2 Case Reports in Medicine
2.CaseReport
A 17-year-old boy presented to the emergency unit com-
plaining of retrosternal chest pain radiating to his left
shoulderandbackforonehour.Fourdaysago,hehasstarted
to receive penicillin treatment due to acute tonsillitis, and,
on the fourth dose of penicillin, he had an episode of severe
itching, nausea, and vomiting. It was accepted as penicillin
allergy, and the treatment was changed to clindamycin
therapy. One hour after the ﬁrst dose of clindamycin, the
retrosternal chest pain has started.
His electrocardiogram (ECG) on admission indicated
acute anterolateral MI with ST segment elevations on leads
DI, Avl, and V2 to V6 and also reciprocal ST depressions
on leads DIII and aVF (Figure 1). He had no risk factors
for coronary artery disease, and his physical examination
was unremarkable, but his blood tests showed elevated tro-
ponin levels as 1.4ng/mL (normal range 0.00–0.11ng/mL)
and leucocytosis and eosinophilia. His echocardiography
showed no pathologic signs of pericarditis, but he had
slightly hypokinetic mid and apical anterior segments of left
ventricle.
He was taken to the invasive laboratory, and coronary
angiography was performed. His angiogram resulted as
totally normal coronary arteries except at about 15mm in
length myocardial bridging at the mid portion of the LAD
(Figure 2). No further interventions were performed, and
he was taken to intensive care unit. Combination of beta-
blocker, acetyl salicylic acid and prednisolone therapy was
started. His symptoms dissolved in half an hour, and during
followupnosymptomsrepeated.Histroponinlevelselevated
up to 18ng/mL as peak and started to decrease then after
gradually. His ECG ﬁndings resolved in the following days
as the ST elevations and reciprocal ST depressions returned
to baseline and the biphasic T waves observed as expected
(Figure 3). He was discharged on the ﬁfth day, and, at the 3-
and 6- month visits, he was free of cardiac complaints.
3. Discussion
In 1991, regarding Kounis syndrome, the ﬁrst case was
reported by Kounis and Zarvas as “allergic angina syn-
drome.” Constantinides declared that even nonserious aller-
gic reactions could provoke atherosclerotic plaque rupture,
in 1995. In 1998, Braunwald pointed out that histamine and
leukotriene-like mediators released during allergic reactions
contracted the coronary blood vessels [11]. Myocardial
infarction due to amoxicillin as an allergen was ﬁrst
described in 1950. To our knowledge, there is no report on
clindamycin causing myocardial ischemic syndromes in the
literature.
Mast cells, the key elements of allergic reactions,
are located between cardiomyocytes and around coronary
arteries in healthy people. Larger amounts are present at
atherosclerotic vessels. They play major role in allergic and
anaphylactoid reactions. After allergen exposure, antigen-
anticor complexes or the allergenitself directly activates mast
cells [9, 11]. Mediators like histamine, leukotrienes, neutral
proteases, and platelet-activating factor are released locally
Figure 1: Anteroseptal ST elevations on leads DI, aVL, V2 to V6,
and reciprocal ST depressions on leads DIII, aVF indicating acute
anterolateral myocardial infarction.
Figure 2: Myocardial bridging at the mid portion of the LAD and
narrowing during systole.
Figure 3: Normal resolution phase of anterolateral myocardial
infarction as biphasic T waves on leads V2 to V6 and DI, aVL.
and to the systemic circulation by mast cell degranulation to
constrict the coronary arteries.
Myocardial bridging is usually an incidental ﬁnding at
coronary angiography, but sometimes the patients may be
admitted to the emergency units with typical or atypical
angina pectoris, ST elevation, or non-ST elevation MI and
very rarely with sudden cardiac death in the presence
of myocardial bridging [12, 13]. It was ﬁrst recognised
at an autopsy by Reyman in 1737 and ﬁrst described
angiographically by Portmann and Iwing in 1960 [14, 15].
The estimated incidence varies from 1.5% to 16% whenCase Reports in Medicine 3
assessed by coronary angiography; however, it’s much higher
in autopsy series as up to 80% [1, 16]. In the vast majority
of the cases, angiographic localization of the bridge is on
the LAD. The right coronary artery or the circumﬂex artery
involvements are very rare [17–19].
Myocardial bridging is usually a clinically silent condi-
tion, and the clinical signiﬁcance of the bridge is determined
by the anatomy of the tunnelled segment, concomitant vaso-
constrictive situations, and atheromatous changes. During
systole,contractionoftheoverlyingmyocardiumcompresses
theunderlying coronarysegment;this compressionmayper-
sistintothediastole,inwhichthemajorityofcoronaryblood
ﬂow occurs normally. Increased heart rate, shortening of
diastole, increased myocardial contraction and ﬂow velocity,
and all causes leading to coronary spasm like exercise, drugs,
or allergic reactions can cause ischemia in patients with
myocardial bridging [20, 21]. The myocardial infarction in
our case may be related to the additive eﬀect of coronary
vasospasm of Type 1 Kounis syndrome and the existing
myocardial bridging on the mid LAD.
In symptomatic patients with myocardial bridging, the
management is usually medical rarely surgical or invasive.
Available medications include beta-blockers and calcium
channel blockers. These drugs have the negative inotropic
propertiesthatslowstheheartrateandelongatesthediastolic
phase to obtain adequate time for the coronary arteries
to maintain the blood ﬂow. Nitrates should generally be
avoided because they can increase the angiographic narrow-
ing due to the increased heart rate and can lead to worsening
of the symptoms. Surgical treatment by dissecting the
overlying myocardial ﬁbers (myotomy) or coronary artery
bypass should be limited to patients with severe symptoms
or recurrent ischemia that persist despite optimal medical
treatment. Coronary stenting may be another treatment
option in retractable cases; however, the restenosis rates and
complications during the procedures limit their frequent
usage [22]. Our patient was successfully treated conserva-
tively with beta-blocker, aspirin, and immunosuppressive
therapy.
4. Conclusions
To the best of our knowledge, it is the ﬁrst case report
in the literature that Type 1 Kounis syndrome overlapping
with preexisting myocardial bridging and causing acute ST
elevation MI in a 17-year-old male patient right after taking
a clindamycin tablette. It should be kept in mind that,
although the myocardial bridging is considered a safe and
simple condition, with the additive vasoconstrictive eﬀects
of allergens, drugs, or the patients, it can cause ischemia and
infarction.
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